Fingolimod Settlement Agreement Begets New Disagreements21 Mar 2022Marcus Klee, Rob YoungsonIn March 2019, Novartis and Pharmascience entered into a settlement agreement giving Pharmascience a non-exhaustive license to sell its generic version of...Read More
